Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
small molecule |
| gptkbp:CASNumber |
1802000-97-7
|
| gptkbp:clinicalTrialPhase |
Phase 1
|
| gptkbp:developedBy |
gptkb:Principia_Biopharma
|
| https://www.w3.org/2000/01/rdf-schema#label |
PRN1371
|
| gptkbp:indication |
bladder cancer
solid tumors |
| gptkbp:intendedUse |
oncology
|
| gptkbp:mechanismOfAction |
FGFR1-4 inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:target |
gptkb:FGFR3
gptkb:FGFR1 gptkb:FGFR4 gptkb:FGFR2 |
| gptkbp:bfsParent |
gptkb:Principia_Biopharma
gptkb:CD332 |
| gptkbp:bfsLayer |
7
|